e-learning
resources
Munich 2014
Sunday, 07.09.2014
New treatments for cough, asthma, COPD and ILDs
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD
J. Knobloch, Y. Yakin, B. Grensemann, S. Körber, D. Jungck, A. Koch (Bochum, Cologne, Germany)
Source:
International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Session:
New treatments for cough, asthma, COPD and ILDs
Session type:
Poster Discussion
Number:
1517
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Knobloch, Y. Yakin, B. Grensemann, S. Körber, D. Jungck, A. Koch (Bochum, Cologne, Germany). Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD. Eur Respir J 2014; 44: Suppl. 58, 1517
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Elevated GM-CSF in COPD may drive defective macrophage phenotype
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Expression of Th1, Th2 and Th17 cytokines in CD4
+
T cells in peripheral blood of asthma patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
The effect of budesonide on TLR expression in alveolar macrophages from smokers
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Oxidative stress drives defective efferocytosis in COPD M2-like macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Systemic characterization of macrophage phenotypes in allergic airway inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Dual role of M2 macrophages in asthma
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
IL-33 and TSLP gene expression are increased in response to human rhinovirus 1B in HDM-treated murine bone marrow-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by cytotoxic/ pro-inflammatory lymphocytes
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
Macrophage subsets in lung tissue of healthy controls and asthma patients
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Additive anti-inflammatory effect of glucocorticoids and PDE4 inhibitors on COPD CD8 cells
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept